載入...
Effect of drug therapy on net cholesterol efflux capacity of HDL-enriched serum in rheumatoid arthritis
BACKGROUND: Patients with rheumatoid arthritis (RA) have increased coronary heart disease (CHD) risk. Some RA therapies may modify this risk, but underlying mechanisms are unclear. HDL’s cholesterol efflux capacity is associated with reduced CHD risk in non-RA populations; however, inflammation may...
Na minha lista:
| 發表在: | Arthritis Rheumatol |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5001900/ https://ncbi.nlm.nih.gov/pubmed/26991245 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.39675 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|